Published September 2021 | Version v1
Journal article

Inhibition of Rev-erbα ameliorates muscular dystrophy

  • 1. Department of Diabetes Complications & Metabolism, Beckman Research Institute of City of Hope, Duarte, CA, 91010 (United States)
  • 2. Diabetes and Beta Cell Biology Center, Division of Endocrinology, Diabetes & Metabolism, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, 15261 (United States)

Description

Highlights: • Rev-erbα ablation in mdx mice protects against muscle damage and wasting. • Loss of Rev-erbα promoted regenerative myogenesis in mdx mice. • Rev-erbα deficiency in dystrophic muscle reduced inflammatory response. • Loss of Rev-erbα in mdx primary myoblasts promoted proliferation and differentiation. Duchene muscular dystrophy leads to progressive muscle structural and functional decline due to chronic degenerative-regenerative cycles. Enhancing the regenerative capacity of dystrophic muscle provides potential therapeutic options. We previously demonstrated that the circadian clock repressor Rev-erbα inhibited myogenesis and Rev-erbα ablation enhanced muscle regeneration. Here we show that Rev-erbα deficiency in the dystrophin-deficient mdx mice promotes regenerative myogenic response to ameliorate muscle damage. Loss of Rev-erbα in mdx mice improved dystrophic pathology and muscle wasting. Rev-erbα-deficient dystrophic muscle exhibit augmented myogenic response, enhanced neo-myofiber formation and attenuated inflammatory response. In mdx myoblasts devoid of Rev-erbα, myogenic differentiation was augmented together with up-regulation of Wnt signaling and proliferative pathways, suggesting that loss of Rev-erbα inhibition of these processes contributed to the improvement in regenerative myogenesis. Collectively, our findings revealed that the loss of Rev-erbα function protects dystrophic muscle from injury by promoting myogenic repair, and inhibition of its activity may have therapeutic utilities for muscular dystrophy.

Availability note (English)

Available from http://dx.doi.org/10.1016/j.yexcr.2021.112766

Additional details

Identifiers

DOI
10.1016/j.yexcr.2021.112766;
PII
S0014482721003190;

Publishing Information

Journal Title
Experimental Cell Research
Journal Volume
406
Journal Issue
2
Journal Page Range
vp.
ISSN
0014-4827
CODEN
ECREAL

INIS

Country of Publication
United States
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
53119137
Subject category
S60: APPLIED LIFE SCIENCES;
Descriptors DEI
ABLATION; BIOLOGICAL REPAIR; CELL PROLIFERATION; INFLAMMATION; INHIBITION; INJURIES; MICE; MYOBLASTS; REGENERATION
Descriptors DEC
ANIMALS; BIOLOGICAL RECOVERY; DISEASES; MAMMALS; MUSCLES; PATHOLOGICAL CHANGES; REPAIR; RODENTS; SYMPTOMS; VERTEBRATES

Optional Information

Copyright
Copyright (c) 2021 Elsevier Inc. All rights reserved.